BMSTX
Price
$14.29
Change
+$0.09 (+0.63%)
Updated
Dec 24 closing price
VIMAX
Price
$333.21
Change
+$2.87 (+0.87%)
Updated
Dec 24 closing price
Ad is loading...

BMSTX vs VIMAX

Header iconBMSTX vs VIMAX Comparison
Open Charts BMSTX vs VIMAXBanner chart's image
MFS Blended Research Mid Cap Eq R3
Price$14.29
Change+$0.09 (+0.63%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$333.21
Change+$2.87 (+0.87%)
VolumeN/A
CapitalizationN/A
BMSTX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMSTX vs. VIMAX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMSTX is a Hold and VIMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. BMSTX (911M). VIMAX pays higher dividends than BMSTX: VIMAX (1.49) vs BMSTX (0.74). BMSTX was incepted earlier than VIMAX: BMSTX (8 years) vs VIMAX (23 years). BMSTX is a more actively managed with annual turnover of: 67.00 vs. VIMAX (13.00). BMSTX has a lower initial minimum investment than VIMAX: BMSTX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 15.92 vs. BMSTX (9.70). VIMAX return over 5 years is better than : 52.16 vs. BMSTX (21.20).
BMSTXVIMAXBMSTX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years23 years-
Gain YTD9.45015.37961%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets911M190B0%
Annual Yield % from dividends0.741.4950%
Returns for 1 year9.7015.9261%
Returns for 3 years8.946.98128%
Returns for 5 years21.2052.1641%
Returns for 10 yearsN/A118.50-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AQN4.480.09
+2.05%
Algonquin Power & Utilities Corp
XYL117.510.37
+0.32%
Xylem
DRUG38.690.04
+0.10%
Bright Minds Biosciences
ARDX4.58-0.24
-4.98%
Ardelyx
GDTC2.37-0.19
-7.42%
CytoMed Therapeutics Limited